Elizabeth Turner

Elizabeth Turner has extensive work experience in the field of market access and pharmaceutical sales. Elizabeth has held key leadership positions in several companies, including Mirum Pharmaceuticals, Galera Therapeutics, Anton Health, Arena Pharmaceuticals, Amgen, Pfizer, and media companies such as Orlando Sentinel, Miami Herald, and Atlanta Journal-Constitution. Throughout their career, Elizabeth has demonstrated a strong track record of successfully building and executing market access strategies, leading teams, and driving commercialization success. Elizabeth has expertise in pricing, distribution, channel strategy, patient services, health economics, reimbursement, and market dynamics. Elizabeth has consistently achieved results, including generating significant sales growth, negotiating preferred coverage, launching new products, and earning multiple awards for their exceptional performance.

Elizabeth Turner has a Bachelor's degree in Mass Communication/Media Studies from the University of South Florida, which they completed in 2000. In 2007, they obtained a Master of Business Administration (M.B.A.) from the University of Central Florida. Currently, they are enrolled in the Wharton Executive Education program to pursue further studies in Business Administration and Management, specifically focusing on Executive Presence and Influence. Elizabeth is expected to complete this program in 2022.